104 related articles for article (PubMed ID: 8773793)
1. Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum.
Bazzett TJ; Falik RC; Becker JB; Albin RL
Brain Res; 1996 Apr; 718(1-2):228-32. PubMed ID: 8773793
[TBL] [Abstract][Full Text] [Related]
2. In vivo studies on the protective role of minocycline against excitotoxicity caused by malonate or N-methyl-d-aspartate.
Goñi-Allo B; Ramos M; Jordán J; Aguirre N
Exp Neurol; 2005 Feb; 191(2):326-30. PubMed ID: 15649488
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate.
Greene JG; Greenamyre JT
J Neurochem; 1995 May; 64(5):2332-8. PubMed ID: 7536810
[TBL] [Abstract][Full Text] [Related]
4. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial inhibitor malonate enhances NMDA toxicity in the neonatal rat striatum.
Maragos WF; Silverstein FS
Brain Res Dev Brain Res; 1995 Aug; 88(1):117-21. PubMed ID: 7493402
[TBL] [Abstract][Full Text] [Related]
6. Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation.
Ferger B; Eberhardt O; Teismann P; de Groote C; Schulz JB
J Neurochem; 1999 Sep; 73(3):1329-32. PubMed ID: 10461928
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of membrane potential modulates malonate-induced striatal excitotoxicity in vivo.
Greene JG; Greenamyre JT
J Neurochem; 1996 Feb; 66(2):637-43. PubMed ID: 8592134
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.
Guidetti P; Schwarcz R
Eur J Neurosci; 1999 Nov; 11(11):3857-63. PubMed ID: 10583474
[TBL] [Abstract][Full Text] [Related]
9. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-methyl-D-asparate-induced neurotoxicity.
Kumar U
J Mol Neurosci; 2008 Jul; 35(3):345-54. PubMed ID: 18483877
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate.
Greene JG; Greenamyre JT
J Neurochem; 1995 Jan; 64(1):430-6. PubMed ID: 7528265
[TBL] [Abstract][Full Text] [Related]
12. Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum.
Kalisch BE; Jhamandas K; Boegman RJ; Beninger RJ
Brain Res; 1994 Dec; 668(1-2):1-8. PubMed ID: 7535651
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptors are involved in the quinolinic acid, but not in the malonate pro-oxidative activity in vitro.
Puntel RL; Nogueira CW; Rocha JB
Neurochem Res; 2005 Mar; 30(3):417-24. PubMed ID: 16018587
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of creatine administration against NMDA and malonate toxicity.
Malcon C; Kaddurah-Daouk R; Beal MF
Brain Res; 2000 Mar; 860(1-2):195-8. PubMed ID: 10727643
[TBL] [Abstract][Full Text] [Related]
15. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
16. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia.
Schulz JB; Weller M; Matthews RT; Heneka MT; Groscurth P; Martinou JC; Lommatzsch J; von Coelln R; Wüllner U; Löschmann PA; Beal MF; Dichgans J; Klockgether T
Cell Death Differ; 1998 Oct; 5(10):847-57. PubMed ID: 10203688
[TBL] [Abstract][Full Text] [Related]
17. MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum.
Santamaría A; Ríos C
Neurosci Lett; 1993 Sep; 159(1-2):51-4. PubMed ID: 8264978
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats.
Maragos WF; Silverstein FS
J Neurochem; 1995 May; 64(5):2362-5. PubMed ID: 7536812
[TBL] [Abstract][Full Text] [Related]
19. ARL-15896, a novel N-methyl-D-aspartate receptor ion channel antagonist: neuroprotection against mitochondrial metabolic toxicity and regional pharmacology.
Greene JG; Porter RH; Greenamyre JT
Exp Neurol; 1996 Jan; 137(1):66-72. PubMed ID: 8566213
[TBL] [Abstract][Full Text] [Related]
20. Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.
Ribeiro CA; Grando V; Dutra Filho CS; Wannmacher CM; Wajner M
J Neurochem; 2006 Dec; 99(6):1531-42. PubMed ID: 17230642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
